ArticleBlood cancer journal2026

Inhibition of BIRC5 and MCL-1 as a potential treatment strategy to overcome drug resistance in Mantle Cell Lymphoma.

Jeremiah Pfitzer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.